|
Welcome to datamethods
|
|
1
|
13803
|
July 24, 2018
|
|
Best model reduction approach for Fine-Gray prediction model
|
|
5
|
53
|
March 27, 2026
|
|
Biomarker evaluation - c-statistic (AUC) and alternatives
|
|
42
|
7553
|
March 27, 2026
|
|
Scoping review + SOCI: to assess DHIS2 applicability for NCD
|
|
2
|
41
|
March 26, 2026
|
|
Experimenting with a Bayesian Partial Proportional Odds Model
|
|
1
|
89
|
March 25, 2026
|
|
Internal Validation with Bayesian models
|
|
6
|
55
|
March 25, 2026
|
|
Is the use of conditional logistic regression necessary in case-control study？
|
|
1
|
51
|
March 25, 2026
|
|
Where are the exceptional responders?
|
|
8
|
1118
|
March 25, 2026
|
|
Author Checklist
|
|
7
|
100867
|
March 24, 2026
|
|
Should one derive risk difference from the odds ratio?
|
|
622
|
79427
|
March 17, 2026
|
|
Trying to understand statistical methods through the lens of replication
|
|
3
|
153
|
March 17, 2026
|
|
Clustering in the denominator: non-independence of starts in racing fatality studies
|
|
1
|
70
|
March 13, 2026
|
|
Statistics Agent Skills for Large Language Models
|
|
14
|
595
|
March 9, 2026
|
|
Estimand when treatment delays disease onset
|
|
4
|
120
|
March 5, 2026
|
|
My favorite distribution vandalized on Wikipedia
|
|
4
|
161
|
March 3, 2026
|
|
Generalizability vs. Transportability in Trials
|
|
61
|
989
|
March 2, 2026
|
|
FDA Draft Guidance: Use of Bayesian Methodology in Clinical Trials of Drug and Biological Products
|
|
10
|
680
|
March 2, 2026
|
|
Never seen this sort or primary endpoint and analysis in an RCT
|
|
17
|
308
|
February 27, 2026
|
|
Change the range not the language on confidence intervals
|
|
33
|
764
|
February 27, 2026
|
|
One-sided significance threshold of less than 0.1 in Phase 2 clinical trial
|
|
7
|
118
|
February 25, 2026
|
|
Narratively generative modeling
|
|
1
|
91
|
February 24, 2026
|
|
Six Entrenched Misconceptions About Meta-Analysis Models
|
|
4
|
212
|
February 22, 2026
|
|
REDCap EHR integration for clinical trials
|
|
17
|
320
|
February 20, 2026
|
|
Statin-related side effects: the recent Lancet publication is biased toward false-negatives
|
|
19
|
465
|
February 19, 2026
|
|
Good reading on when "doubly robust" is worth the effort?
|
|
8
|
2515
|
February 18, 2026
|
|
Significance versus hypothesis testing
|
|
13
|
262
|
February 17, 2026
|
|
RMS Semiparametric Ordinal Longitudinal Model
|
|
112
|
15080
|
February 16, 2026
|
|
Dichotomization
|
|
77
|
4736
|
February 8, 2026
|
|
“False Transport” of RCT entry criteria to clinical protocols
|
|
1
|
147
|
February 7, 2026
|
|
ABCLOC: bootstrap method for overfitting-corrected model performance metrics
|
|
3
|
72
|
February 7, 2026
|